Judge to Decide if Monsanto Roundup Cancer Lawsuits Move Forward

Plaintiffs claim they or their loved ones developed non-Hodgkin Lymphoma due to exposure to glyphosate

A federal judge in San Francisco will hear from expert witnesses on the science and safety of glyphosate at critical hearing starting Monday that will determine if plaintiffs around the country can move forward with their legal action against Monsanto over cancer claims.

More than 365 pending lawsuits against the agribusiness giant have been centralized in multidistrict litigation under U.S. District Judge Vince Chhabria. The plaintiffs claim they or their loved ones developed non-Hodgkin Lymphoma (NHL) due to exposure to glyphosate, the active ingredient in Monsanto’s Roundup weedkiller.

During the week-long hearing—dubbed “Science Week”—epidemiologists, oncologists, toxicologists and other scientists representing both sides will offer testimony about glyphosate.

The judge will not decide whether or not glyphosate causes cancer. Rather, Chhabria will determine if the experts providing scientific opinions regarding causation will be permitted to testify at trial, explained Baum, Hedlund, Aristei & Goldman, one of the law firms leading the litigation.